Investigation of NRXN1 Deletions: Clinical and Molecular Characterization Mindy Preston Dabell,1 Jill A
RESEARCH ARTICLE Investigation of NRXN1 Deletions: Clinical and Molecular Characterization Mindy Preston Dabell,1 Jill A. Rosenfeld,1 Patricia Bader,2 Luis F. Escobar,3 Dima El-Khechen,3 Stephanie E. Vallee,4 Mary Beth Palko Dinulos,4 Cynthia Curry,5 Jamie Fisher,5 Raymond Tervo,6 Mark C. Hannibal,7 Kiana Siefkas,8 Philip R. Wyatt,9 Lauren Hughes,9 Rosemarie Smith,10 Sara Ellingwood,10 Yves Lacassie,11 Tracy Stroud,12 Sandra A. Farrell,13 Pedro A. Sanchez-Lara,14 Linda M. Randolph,14 Dmitriy Niyazov,15 Cathy A. Stevens,16 Cheri Schoonveld,17 David Skidmore,18 Sara MacKay,18 Judith H. Miles,19 Manikum Moodley,20 Adam Huillet,21 Nicholas J. Neill,1 Jay W. Ellison,1 Blake C. Ballif,1 and Lisa G. Shaffer1* 1Signature Genomic Laboratories, PerkinElmer, Inc., Spokane, Washington 2Northeast Indiana Genetic Counseling Center, Fort Wayne, Indiana 3Medical Genetics and Neurodevelopmental Center, Peyton Manning Children’s Hospital at St. Vincent, Indianapolis, Indiana 4Department of Pediatrics, Section of Medical Genetics, The Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 5Genetic Medicine of Central California, Fresno, California 6Gillette Children’s Specialty Healthcare, St. Paul, Minnesota 7Division of Medical Genetics, University of Washington School of Medicine, Seattle, Washington 8Children’s Village and Yakima Valley Memorial Hospital, Yakima, Washington 9Orillia Soldiers’ Memorial Hospital, Orillia, Ontario, Canada 10Division of Genetics, Maine Medical Center, Portland, Maine 11Department
[Show full text]